Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442323 · ClinicalTrials.gov registry record · NA
A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02442323 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT02442323, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Despite evidence regarding the benefits of physical activity in various cancer patient populations, the effects of a home-based walking program for pancreatic cancer patients have been under-explored. The aims of the proposed pilot project are to: (1) Assess the feasibility of implementing a 12-week, home-based walking program among pancreatic cancer patients; and (2) Examine the effects of a 12-week, home-based walking program on quality of life (QOL) and symptoms among pancreatic cancer patients.
Interventions
- BEHAVIORAL Walking Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-08-09 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02442323
The ClinicalTrials.gov registry entry for NCT02442323 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walking Intervention is the first listed.
NCT02442323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02442323 about?
NCT02442323 is a clinical study titled "A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients". Despite evidence regarding the benefits of physical activity in various cancer patient populations, the effects of a home-based walking program for pancreatic cancer patients have been under-explored. The aims of the proposed pilot project are to: (1) Assess the feasibility of implementing a 12-week...
What is the current status of trial NCT02442323?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-08-09. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT02442323?
The interventions under investigation include: Walking Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02442323?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.